Pakke med 10 hetteglass6 på lagerSpar 25 %PT-141 10 mg
Bremelanotid melanokortinagonist
PT-141 bremelanotide research peptide, Australian-shipped. Lab-verified ≥99% purity.
Kun til forskningsbruk. Denne forbindelsen selges strengt til in vitro-forskning og laboratorieformål og er ikke beregnet for menneskelig konsum eller terapeutisk bruk. Ved kjøp bekrefter du at du er en kvalifisert forsker og godtar vår fullstendige ansvarsfraskrivelse.
Bare 6 pakker igjen
Syntetisk melanokortinreseptoragonist studert for virkninger på neurale veier knyttet til seksuell respons i forskningsapplikasjoner.
PT-141 (bremelanotide) is a synthetic melanocortin-receptor agonist derived from the alpha-melanocyte-stimulating hormone (α-MSH) family. It is one of the most studied melanocortin-pathway research peptides outside of the tanning-active analogues. Quantum Labs supplies PT-141 as a lyophilised powder for Australian research applications.
Research on PT-141 has covered the central melanocortin pathway, particularly MC3R and MC4R receptor activation, and pre-clinical models of sexual-response signalling. Material is HPLC-verified to ≥99% purity and ships from Australian stock; supplied for laboratory research use only.
Mekanisme
Forskning tyder på primær agonisme av MC4R med virkninger i sentralnervesystemet på nevrokjemiske markører hos studiedeltakere.
HPLC-verifisert mot en renhetsspesifikasjon på ≥99 %. Uavhengig testet av akkrediterte tredjepartslaboratorier.
PT-141 — vanlige spørsmål
What is PT-141?
PT-141 (bremelanotide) is a synthetic melanocortin-receptor agonist studied in research models of central melanocortin-pathway signalling. It is one of the most-studied research peptides in the melanocortin family alongside the tanning-active analogues.
Is PT-141 legal in Australia?
PT-141 is restricted for compounded human therapeutic supply in Australia and remains available for research and laboratory use when supplied without therapeutic representation. Quantum Labs supplies PT-141 for research use only.
What receptors does PT-141 target?
PT-141 primarily activates the melanocortin-3 (MC3R) and melanocortin-4 (MC4R) receptors. Research has focused on the central melanocortin pathway, particularly downstream signalling in MC4R-rich brain regions.
What is bremelanotide?
Bremelanotide is the generic name for PT-141. It is a cyclic synthetic peptide derived from the α-MSH lineage. PT-141 is the research-code designation; bremelanotide is the pharmaceutical name.
What is the typical PT-141 research dosage?
Published research protocols have used wide dose ranges depending on the model and delivery route (intranasal, subcutaneous). Human dosing is not established. Researchers should consult primary literature for protocol-specific guidance.
Guider relatert til PT-141
Forskere utforsker også
UtvalgtPakke med 10 hetteglassSpar 17 %HGH
Lyofilisert pulver10 IU · 4 strengths
Rekombinant humant veksthormon
I 2 stacker
Pakke med 10 hetteglassSpar 18 %Tesamorelin
Lyofilisert pulver10 mg · 3 strengths
Stabilisert GHRH-analog
I 1 stack
UtvalgtPakke med 10 hetteglassSpar 22 %CJC-1295 + Ipamorelin
Lyofilisert pulver5 mg + 5 mg
Klassisk GHRH + ghrelinmimetisk stack
I 2 stacker